In the past week, QDEL stock has gone down by -9.90%, with a monthly decline of -19.96% and a quarterly plunge of -45.31%. The volatility ratio for the week is 3.70%, and the volatility levels for the last 30 days are 3.51% for QuidelOrtho Corporation The simple moving average for the past 20 days is -12.67% for QDEL’s stock, with a -42.22% simple moving average for the past 200 days.
Is It Worth Investing in QuidelOrtho Corporation (NASDAQ: QDEL) Right Now?
The stock has a 36-month beta value of 0.18. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 2 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for QDEL is 48.11M, and at present, short sellers hold a 4.68% of that float. On April 18, 2024, the average trading volume of QDEL was 1.09M shares.
QDEL) stock’s latest price update
The stock price of QuidelOrtho Corporation (NASDAQ: QDEL) has jumped by 0.04 compared to previous close of 38.71. Despite this, the company has seen a fall of -9.90% in its stock price over the last five trading days. Seeking Alpha reported 2024-04-13 that QuidelOrtho’s profitability has been impacted by higher depreciation and non-operating expenses, but improvements in gross margins and reduced expenses are expected in 2024. The company’s revenue growth in 2023 was below targets, with the Labs segment outperforming expectations and the Transfusion Medicine, Point of Care, and Molecular Diagnostics segments underperforming. Internal weaknesses such as management changes, declining R&D spending, product recalls, and high indebtedness pose challenges for QuidelOrtho’s growth prospects.
Analysts’ Opinion of QDEL
Many brokerage firms have already submitted their reports for QDEL stocks, with UBS repeating the rating for QDEL by listing it as a “Sell.” The predicted price for QDEL in the upcoming period, according to UBS is $42 based on the research report published on March 04, 2024 of the current year 2024.
JP Morgan, on the other hand, stated in their research note that they expect to see QDEL reach a price target of $37, previously predicting the price at $66. The rating they have provided for QDEL stocks is “Underweight” according to the report published on February 14th, 2024.
Citigroup gave a rating of “Neutral” to QDEL, setting the target price at $72 in the report published on December 11th of the previous year.
QDEL Trading at -19.31% from the 50-Day Moving Average
After a stumble in the market that brought QDEL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.25% of loss for the given period.
Volatility was left at 3.51%, however, over the last 30 days, the volatility rate increased by 3.70%, as shares sank -18.20% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -43.64% lower at present.
During the last 5 trading sessions, QDEL fell by -9.75%, which changed the moving average for the period of 200-days by -53.41% in comparison to the 20-day moving average, which settled at $43.91. In addition, QuidelOrtho Corporation saw -47.46% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at QDEL starting from Busky Joseph M, who purchase 2,150 shares at the price of $46.35 back on Feb 23 ’24. After this action, Busky Joseph M now owns 2,150 shares of QuidelOrtho Corporation, valued at $99,663 using the latest closing price.
Stock Fundamentals for QDEL
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.48 for the gross margin
The net margin for QuidelOrtho Corporation stands at -0.0. The total capital return value is set at 0.02. Equity return is now at value -0.20, with -0.12 for asset returns.
Based on QuidelOrtho Corporation (QDEL), the company’s capital structure generated 0.33 points at debt to capital in total, while cash flow to debt ratio is standing at 0.11. The debt to equity ratio resting at 0.49. The interest coverage ratio of the stock is 0.94.
Currently, EBITDA for the company is 703.5 million with net debt to EBITDA at 6.83. When we switch over and look at the enterprise to sales, we see a ratio of 1.7. The receivables turnover for the company is 6.14for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.57.
Conclusion
To sum up, QuidelOrtho Corporation (QDEL) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
